Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing
Reexamination Certificate
2008-10-22
2011-12-13
Andres, Janet (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Amino nitrogen containing
C514S649000
Reexamination Certificate
active
08076516
ABSTRACT:
Provided are amine derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
REFERENCES:
patent: 3911151 (1975-10-01), Yokoyama et al.
patent: 5227372 (1993-07-01), Folkman
patent: 2002/0058685 (2002-09-01), Hamilton
patent: 2003/0032078 (2003-02-01), Travis
patent: 2003/0186981 (2003-10-01), Hamilton et al.
patent: 2004/0186061 (2004-09-01), Meese et al.
patent: 2006/0069078 (2006-03-01), Rando
patent: 2006/0069110 (2006-03-01), Andersen et al.
patent: 2006/0116373 (2006-06-01), Dollinger et al.
patent: 2006/0211694 (2006-09-01), Devadas
patent: 2006/0252107 (2006-11-01), Kubota et al.
patent: 2006/0281812 (2006-12-01), Slatter et al.
patent: 2006/0281821 (2006-12-01), Palczewski et al.
patent: 2007/0072920 (2007-03-01), Hellberg et al.
patent: 2007/0149480 (2007-06-01), Ghosh et al.
patent: WO 03/059872 (2003-07-01), None
patent: WO 2004/030671 (2004-04-01), None
patent: WO 2005/105760 (2005-11-01), None
patent: WO 2008/011560 (2008-01-01), None
patent: WO 2008/021388 (2008-02-01), None
patent: WO 2008/131368 (2008-04-01), None
patent: WO 2008/077057 (2008-06-01), None
patent: WO 2008/005794 (2009-08-01), None
Rangisetty et. al., “1-[2-Methocy-5-(3-phenylpropyl]-2-aminopropane unexpectedly shows 5-HT2A Serotonin Receptor Affinity and Antagonist Character”, J. Med. Chem. 2001, 44, pp. 3283-3291.
Tavora de Albuquerque Silva, A. et al., Mini Reviews in Medicinal Chemistry, vol. 5, 2005, 893-914.
Zanon-Moreno, V. et al., Molecular Vision, vol. 14, 2008, 2143-47.
GB0819399.7 Search Report dated Apr. 1, 2009.
Golczak et al., “Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle,” PNAS 102(23):8162-8167 (2005).
Maeda et al., “Evaluation of the role of the retinol G protein-coupled receptor (RGR) in the vertebrate retina in vivo,” J. Neurochem. 85(4):944-956 (2003).
Mata et al., “Isomerization and Oxidation of Vitamin A in Cone-Dominant Retinas: A Novel Pathway for Visual-Pigment Regeneration in Daylight,” Neuron 36:69-80 (2002).
Minami et al., “Enzymatic Approach to Unnatural Glycosides with Diverse Aglycon Scaffolds Using Glycosyltransferase VinC,” JACS 127:6148-6149 (2005).
Hong Feng
Kubota Ryo
Kuksa Vladimir A.
Little, Jr. Thomas L.
Orme Mark W.
Acucela Inc.
Andres Janet
Reese Heidi
Wilson Sonsini Goodrich & Rosati
LandOfFree
Amine derivative compounds for treating ophthalmic diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amine derivative compounds for treating ophthalmic diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amine derivative compounds for treating ophthalmic diseases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4297360